Moreover, after knocking down FOXA1, the variation of Hallmarks pathway in cells and the variation of Hallmarks pathway in BC patient samples that reached pCR showed a strong significant negative correlation R = -0.971, p < 0.001 (Supplementary Fig. 4F). The gene discussed is FOXA1; the disease is breast cancer.